Bryan Giraudo
Director of Finance/CFO en GOSSAMER BIO, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Bryan Giraudo is an Independent Director at Valerio Therapeutics SA since 2021.
He is also an Independent Director at Protagonist Therapeutics, Inc. since 2018.
Additionally, Mr. Giraudo serves as the Chief Operating & Financial Officer at Gossamer Bio, Inc. since 2021.
Previously, Mr. Giraudo worked as a Senior Managing Director at Leerink Partners LLC from 2009 to 2018.
Prior to that, he was a Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009.
He also held a position as a Managing Director at Pierce Fenner & Smith, Inc.Mr. Giraudo completed his undergraduate degree from Georgetown University in 1997.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GOSSAMER BIO, INC.
0.21% | 27/03/2024 | 472 747 ( 0.21% ) | 557 841 $ | 31/03/2024 |
| 02/01/2024 | 18 000 ( 0.03% ) | 520 740 $ | 31/03/2024 |
Cargos activos de Bryan Giraudo
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 16/05/2018 |
| GOSSAMER BIO, INC. | Director of Finance/CFO | 07/05/2018 |
| VALERIO THERAPEUTICS | Director/Board Member | 23/11/2021 |
Antiguos cargos conocidos de Bryan Giraudo.
| Empresas | Cargo | Fin |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Corporate Officer/Principal | 01/05/2018 |
| Merrill Lynch & Co., Inc. | Corporate Officer/Principal | 01/07/2009 |
| Pierce Fenner & Smith, Inc. | Corporate Officer/Principal | - |
Formación de Bryan Giraudo.
| Georgetown University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| VALERIO THERAPEUTICS | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
| Pierce Fenner & Smith, Inc. | Finance |
| Merrill Lynch & Co., Inc. | Finance |
- Bolsa de valores
- Insiders
- Bryan Giraudo
